KIF1B and myeloid sarcoma: Subsequently, Hares et al. (2014) analyzed 27 MS cases and 13 control cases unrelated to neurological diseases in 2014, and find that mRNA expression of KIF5A, KIF21B, and KIF1B and KIF5A protein expression in the gray matter of MS patients are significantly reduced compared with controls.